Azamollugin, a mollugin derivative, has inhibitory activity on MyD88- and TRIF-dependent pathways DOI
Yuki Nakajima,

Hitomi Nishino,

Kazunori Takahashi

et al.

Journal of Natural Medicines, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 16, 2024

Language: Английский

Molecular mechanisms behind the inhibitory effects of ginsenoside Rg3 on hepatic fibrosis: a review DOI
Zhao-feng Tian,

Rui‐yi Hu,

Zi Wang

et al.

Archives of Toxicology, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 27, 2024

Language: Английский

Citations

1
Azamollugin, a mollugin derivative, has inhibitory activity on MyD88- and TRIF-dependent pathways DOI
Yuki Nakajima,

Hitomi Nishino,

Kazunori Takahashi

et al.

Journal of Natural Medicines, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 16, 2024

Language: Английский

Citations

0